SAN DIEGO--(BUSINESS WIRE)--Silicon Biosystems, Inc., a provider of specialized molecular and cellular biology technology, announced today its entry with Fox Chase Cancer Center in Philadelphia, PA, into an agreement for the company’s DEPArray™ technology.
